Hexagon Nutrition Ltd.

•

hexagonnutrition.comBSE: 544785NSE: HEXAGON

Market Cap₹ 828 Cr.

Current Price

High / Low₹ 78 / 48

Stock P/E21.7

Book Value₹ 20

Price to Book3.41

Dividend Yield0.00 %

ROCE17.3 %

ROE18.2 %

Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Latest quarter profit grew 1166.6% YoY, showing strong momentum
Institutional investors have been accumulating - FII+DII up 6.7pp
Company maintains a comfortable, low leverage position

CONS

A large part of profit comes from other income (45.3% of PBT)
Company has a low return on capital employed of 10.4%
Contingent liabilities are large at 55.3% of net worth
Recurring exceptional / one-off items are inflating headline profit
Company has delivered a poor profit growth of 9.4% over past five years
Operating margins have contracted to 10.3% from 13.4%

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1899.00	37.67	455633.71	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9100.00	82.59	241576.41	0.33	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4850.00	84.58	184478.41	0.78	566.00	3.28	4921.00	57.32	19.27	33.81
4.	CIPLA	1385.00	33.19	111888.39	0.94	785.55	-39.18	7119.28	4.13	16.00	16.73
5.	ZYDUSLIFE	1121.00	24.78	111820.18	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
6.	LAURUSLABS	1840.00	90.93	99417.45	0.11	362.07	123.94	2026.31	29.10	18.20	31.50
7.	LUPIN	2111.00	17.46	96528.82	0.85	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	DRREDDY	1154.00	29.89	96322.06	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
9.	MANKIND	2328.55	47.09	96179.61	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
10.	AUROPHARMA	1653.30	25.62	95127.23	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2427.00	38.10	68495.93	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	HEXAGON	67.38	21.83	828.22	0.00	8.07	—	104.31	-2.08	17.37	11.25

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2025	Jun 2025	Mar 2026	Jun 2026
	83	63	98	101
	75	57	84	91
Operating Profit	9	6	14	10
OPM %	10.28%	9.27%	14.22%	10.07%
	2	2	6	3
Interest	1	0	1	1
Depreciation	1	1	2	1
Profit before Tax	9	8	18	13
Tax %	25.56%	25.26%	25.11%	25.72%
Net Profit	7	6	14	10
	0.60	0.54	1.23	0.82

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	68	70	92	119	99	87	107	114	132	157	347
	61	68	97	108	88	80	94	115	120	141	308
Operating Profit	7	3	-5	11	10	7	13	-1	13	16	39
OPM %	10.10%	3.62%	-5.23%	9.39%	10.60%	8.45%	12.02%	-0.80%	9.59%	10.31%	11.15%
	0	1	1	3	1	3	2	2	6	7	14
Interest	2	2	2	2	1	1	1	1	1	4	2
Depreciation	3	4	4	3	3	2	2	3	3	3	6
Profit before Tax	1	-2	-9	9	8	7	13	-3	14	16	48
Tax %	120.46%	26.50%	22.44%	26.14%	6.81%	24.08%	29.03%	-17.83%	25.20%	26.70%	25.38%
Net Profit	-0	-1	-7	6	7	6	9	-3	10	12	36
EPS	0.00	0.00	0.00	0.00	0.60	0.46	0.73	-0.25	0.95	1.05	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	29.14%	18.55%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: 12%
5 Years:: 10%
3 Years:: 14%

COMPOUNDED PROFIT GROWTH

10 Years:: 24%
5 Years:: 9%
3 Years:: 9%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: —

RETURN ON EQUITY

10 Years:: 7%
5 Years:: 12%
3 Years:: 10%
Last Year:: 18%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	11	11	11	11	11	11	11	11	11	11
	17	29	22	27	35	37	44	39	49	56
	16	15	25	15	13	11	21	26	40	35
Trade Payables	11	15	17	18	14	12	15	27	15	9
	8	22	19	22	22	22	24	22	22	24
Total Liabilities	64	91	94	93	95	93	115	125	137	135
	28	26	25	24	21	20	20	22	25	28
Capital Work in Progress	0	0	0	0	0	0	2	1	2	0
	7	12	7	12	12	16	20	16	8	14
	10	17	23	15	17	19	27	27	27	29
	0	0	0	0	0	0	0	0	24	22
Cash & Bank	1	10	2	2	7	7	5	6	5	4
	18	26	38	41	38	31	41	53	46	37
Total Assets	64	91	94	93	95	93	115	125	137	135

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	-0	-10	-21	12	6	4	8	-2	12
Cash from Investing	-0	-6	3	-1	-2	-11	-8	-8	2
Cash from Financing	0	25	10	-5	-4	7	3	11	-13
	-1	8	-8	5	-1	-3	2	1	-0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
PER SHARE
EPS (₹)	-0.03	-0.13	-0.62	0.57	0.67	0.51	0.81	-0.28	0.95	1.05
Book Value (₹)	2.59	3.62	3.00	3.47	4.17	4.32	4.98	4.49	5.45	6.04
Dividend per Share (₹)	0.00	0.00	0.00	0.00	0.00	0.15	0.15	0.00	0.00	0.00
Cash EPS (₹)	0.28	0.19	-0.29	0.87	0.92	0.71	0.99	-0.04	1.21	1.34
PROFITABILITY
Operating Margin %	10.51%	4.28%	-3.63%	11.61%	13.14%	11.00%	13.39%	4.44%	9.59%	10.31%
Net Margin %	-0.43%	-1.91%	-7.39%	5.32%	7.48%	6.53%	8.37%	-2.72%	7.91%	7.38%
ROE %	-1.13%	-4.26%	-18.67%	17.78%	17.52%	12.12%	17.37%	-5.92%	19.00%	18.19%
ROCE %	8.42%	-0.47%	-9.88%	15.30%	13.05%	11.75%	16.44%	-1.38%	15.22%	17.34%
	-0.45%	-1.88%	-7.31%	6.75%	7.85%	6.06%	8.59%	-2.58%	7.98%	8.53%
EFFICIENCY
Debtor Days	56	72	85	74	67	57	49	62	66	54
Inventory Days	58	64	79	59	60	75	79	87	75	66
Payable Days	122	139	123	103	122	104	96	119	113	56
	-7	-3	42	29	4	27	32	31	28	64
FINANCIAL HEALTH
Debt to Equity (x)	0.57x	0.31x	0.58x	0.32x	0.24x	0.21x	0.33x	0.45x	0.55x	0.45x
Interest Coverage (x)	1.62x	-0.15x	-3.70x	5.27x	7.90x	8.38x	18.60x	-0.89x	10.89x	4.98x
	1.04x	1.84x	1.40x	1.73x	2.15x	2.00x	1.88x	1.58x	1.72x	1.99x
GROWTH
Revenue Growth %	37.66%	4.25%	30.38%	29.47%	-16.91%	-11.89%	22.54%	6.86%	15.90%	18.59%
Operating Profit Growth %	42.83%	-54.14%	-202.46%	513.74%	-5.97%	-26.25%	49.22%	-64.57%	260.99%	27.53%
Net Profit Growth %	-122.36%	-395.21%	-367.03%	193.22%	16.74%	-23.02%	57.02%	-134.70%	437.29%	10.62%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	437.29%	10.62%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	3.21x	2.36x

Shareholding Pattern

Numbers in percentages

	Sep 2014	Jul 2015	Aug 2016	Sep 2017	Sep 2018	Aug 2019	Jun 2026
	0.00	100.00	100.00	100.00	100.00	99.67	64.29
	0.00	0.00	0.00	0.00	0.00	0.00	0.29
	0.00	0.00	0.00	0.00	0.00	0.00	6.42
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	100.00	0.00	0.00	0.00	0.00	0.33	28.99

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-01

General Updates

2026-09-01 - Hexagon Nutrition Limited has informed the Exchange about General Updates

2026-09-01

General Updates

2026-09-01 - Hexagon Nutrition Limited has informed the Exchange about General Updates

2026-09-01

Copy of Newspaper Publication

2026-09-01 - Hexagon Nutrition Limited has informed the Exchange about Copy of Newspaper Publication - Information regarding 33rd Annual General Meeting of the Company to be held through Video Conferencing / Other Audio Visual Means and Remote e-voting

2026-08-31

Shareholders meeting

2026-08-31 - Hexagon Nutrition Limited has informed the Exchange regarding Notice of undefined to be held on September 22, 2026

2026-08-26

Copy of Newspaper Publication

2026-08-26 - Hexagon Nutrition Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-19

Updates

2026-08-19 - Hexagon Nutrition Limited has informed the Exchange regarding 'Disclosure Under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011, Ms. Anuradha Kelkar, Promoter group member of the Company acquired 15,000 Equity shares'.

2026-08-19

Updates

2026-08-19 - Hexagon Nutrition Limited has informed the Exchange regarding 'Disclosure Under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011, Mr. Vikram Kelkar, Promoter and Managing Director of the Company acquired 16,300 Equity shares '.

2026-08-19

Updates

2026-08-19 - Hexagon Nutrition Limited has informed the Exchange regarding 'Disclosure Under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011, this is to inform you that Dr. Nikhil Kelkar, Promoter and Joint Managing Director of the Company acquired 16,400 Equity shares '.

2026-08-18

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-18 - Hexagon Nutrition Limited has informed the Exchange about Transcript

News

Recent coverage and analyst commentary for HEXAGON

Loading news…

🤖

AI Stock Analyst

Hexagon Nutrition Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1899.00

37.67

455633.71

0.84

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9100.00

82.59

241576.41

0.33

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4850.00

84.58

184478.41

0.78

566.00

3.28

4921.00

57.32

19.27

33.81

CIPLA

1385.00

33.19

111888.39

0.94

785.55

-39.18

7119.28

4.13

16.00

16.73

ZYDUSLIFE

1121.00

24.78

111820.18

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

LAURUSLABS

1840.00

90.93

99417.45

0.11

362.07

123.94

2026.31

29.10

18.20

31.50

LUPIN

2111.00

17.46

96528.82

0.85

1416.98

16.01

8276.89

34.28

28.86

29.59

DRREDDY

1154.00

29.89

96322.06

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

MANKIND

2328.55

47.09

96179.61

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

AUROPHARMA

1653.30

25.62

95127.23

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

GLENMARK

2427.00

38.10

68495.93

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

HEXAGON

67.38

21.83

828.22

0.00

8.07

—

104.31

-2.08

17.37

11.25

Mar 2025

Jun 2025

Mar 2026

Jun 2026

101

Operating Profit

OPM %

10.28%

9.27%

14.22%

10.07%

Interest

Depreciation

Profit before Tax

Tax %

25.56%

25.26%

25.11%

25.72%

Net Profit

0.60

0.54

1.23

0.82

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

TTM

119

107

114

132

157

347

108

115

120

141

308

Operating Profit

-5

-1

OPM %

10.10%

3.62%

-5.23%

9.39%

10.60%

8.45%

12.02%

-0.80%

9.59%

10.31%

11.15%

Interest

Depreciation

Profit before Tax

-2

-9

-3

Tax %

120.46%

26.50%

22.44%

26.14%

6.81%

24.08%

29.03%

-17.83%

25.20%

26.70%

25.38%

Net Profit

-0

-1

-7

-3

EPS

0.00

0.60

0.46

0.73

-0.25

0.95

1.05

—

Dividend Payout %

0.00%

29.14%

18.55%

0.00%

—

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Trade Payables

Total Liabilities

115

125

137

135

Capital Work in Progress

Cash & Bank

Total Assets

115

125

137

135

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

-0

-10

-21

-2

Cash from Investing

-0

-6

-1

-2

-11

-8

Cash from Financing

-5

-4

-13

-1

-8

-1

-3

-0

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

PER SHARE

EPS (₹)

-0.03

-0.13

-0.62

0.57

0.67

0.51

0.81

-0.28

0.95

1.05

Book Value (₹)

2.59

3.62

3.00

3.47

4.17

4.32

4.98

4.49

5.45

6.04

Dividend per Share (₹)

0.00

0.15

0.00

Cash EPS (₹)

0.28

0.19

-0.29

0.87

0.92

0.71

0.99

-0.04

1.21

1.34

PROFITABILITY

Operating Margin %

10.51%

4.28%

-3.63%

11.61%

13.14%

11.00%

13.39%

4.44%

9.59%

10.31%

Net Margin %

-0.43%

-1.91%

-7.39%

5.32%

7.48%

6.53%

8.37%

-2.72%

7.91%

7.38%

ROE %

-1.13%

-4.26%

-18.67%

17.78%

17.52%

12.12%

17.37%

-5.92%

19.00%

18.19%

ROCE %

8.42%

-0.47%

-9.88%

15.30%

13.05%

11.75%

16.44%

-1.38%

15.22%

17.34%

-0.45%

-1.88%

-7.31%

6.75%

7.85%

6.06%

8.59%

-2.58%

7.98%

8.53%

EFFICIENCY

Debtor Days

Inventory Days

Payable Days

122

139

123

103

122

104

119

113

-7

-3

FINANCIAL HEALTH

Debt to Equity (x)

0.57x

0.31x

0.58x

0.32x

0.24x

0.21x

0.33x

0.45x

0.55x

0.45x

Interest Coverage (x)

1.62x

-0.15x

-3.70x

5.27x

7.90x

8.38x

18.60x

-0.89x

10.89x

4.98x

1.04x

1.84x

1.40x

1.73x

2.15x

2.00x

1.88x

1.58x

1.72x

1.99x

GROWTH

Revenue Growth %

37.66%

4.25%

30.38%

29.47%

-16.91%

-11.89%

22.54%

6.86%

15.90%

18.59%

Operating Profit Growth %

42.83%

-54.14%

-202.46%

513.74%

-5.97%

-26.25%

49.22%

-64.57%

260.99%

27.53%

Net Profit Growth %

-122.36%

-395.21%

-367.03%

193.22%

16.74%

-23.02%

57.02%

-134.70%

437.29%

10.62%

0.00%

437.29%

10.62%

VALUATION

P/E (x)

0.00x

P/B (x)

0.00x

Dividend Yield %

0.00%

0.00x

3.21x

2.36x

Sep 2014

Jul 2015

Aug 2016

Sep 2017

Sep 2018

Aug 2019

Jun 2026

0.00

100.00

99.67

64.29

0.00

0.29

0.00

6.42

Government

0.00

100.00

0.00

0.33

28.99

Hexagon Nutrition Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Hexagon Nutrition Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI